Introduction {#sec1_1}
============

Renal dysfunction due to deposition of oxalate in renal tissue is a relatively rare condition, and it is termed oxalate neuropathy \[[@B1]\]. Oxalate nephropathy can be divided into acute and chronic forms. It is well known that acute oxalate nephropathy can be caused by accidental or suicidal ingestion of ethylene glycol \[[@B2]\]. Among chronic forms, hereditary primary hyperoxaluria is relatively well known, and its pathogenesis is under intense investigation \[[@B3]\]. Case reports of acquired chronic oxalate nephropathy, on the other hand, are rare. Chronic oxalate nephropathy may not be well recognized. This condition is reportedly attributable to chronic excessive oxalate consumption and enteric malabsorption. Chronic excessive consumption of oxalate is more likely to be involved in this condition as compared to enteric malabsorption \[[@B4]\]. Cases attributable to enteric malabsorption are considered to result from gastrointestinal surgery or gastrointestinal diseases, such as Crohn disease, and its pathological condition is not clearly understood \[[@B5]\]. Here, we report a rare case of acquired chronic oxalate nephropathy with the characteristic echo findings and discuss the condition, including pathogenesis.

Case Report {#sec1_2}
===========

A 70-year-old woman was referred by a local physician to our hospital for detailed investigation of renal function. On admission, her height was 159 cm, weight was 48 kg, body temperature was 36.2°C, pulse was 72 bpm, and blood pressure was 154/74 mm Hg. Her physical findings were not remarkable. Family history was not remarkable except for pancreatic cancer of her father.

Twenty-six years before, the patient had developed intestinal obstruction and undergone small bowel resection. Although the small bowel was partially resected, it was unknown how long the resected small bowel was due to lack of medical records. After the small bowel resection, the patient had often experienced diarrhea or loose stools. Ten years prior to admission, the patient had undergone cholecystectomy for gallstones. Her chronic diarrhea had been aggravated after cholecystectomy. Eight years before, the patient had undergone extracorporeal shock wave transurethral lithotripsy for renal stones. The collected stones were calcium oxalate stones. Her renal function at that time was unknown. Approximately 3 years before, the patient had experienced further aggravation of chronic diarrhea and started to receive treatment for diarrhea, hypertension, and dyslipidemia at a local clinic. Amlodipine, atorvastatin, and an antiflatulent were started. Laboratory findings at that time were blood urea nitrogen (BUN) 9.1 mg/dL, creatinine (Cr) 0.79 mg/dL, and hemoglobin (Hb) 11.2 g/dL. Since then, the patient had experienced diarrhea several times a day and rarely had normal stools. In February of the year prior to admission, laboratory findings showed renal dysfunction (BUN 21.3 mg/dL, Cr 1.23 mg/dL, and Hb 11.2 g/dL). There was no hematuria or proteinuria. In September of that year, laboratory findings showed aggravation of renal function (BUN 52.7 mg/dL, Cr 3.09 mg/dL, and Hb 7.8 g/dL). The patient was admitted to our hospital for further examination and treatment.

The test results on admission are shown in Table [1](#T1){ref-type="table"}. Her renal function showed further aggravation (Cr 3.36 mg/dL). The levels of urinary beta-2 microglobulin and urinary NAG were elevated. Blood gas analysis showed metabolic acidosis. Daily urinary excretion of calcium oxalate measured by 24-hour urine collection was 141 mg/day (reference value, 9.0--37.7 mg/day).

Figure [1](#F1){ref-type="fig"} shows the plain abdominal computed tomography image. There were no significant abnormalities, although there was mild dilatation of the left renal pelvis and urinary tract probably attributable to past effects of calcium oxalate stones.

Figure [2](#F2){ref-type="fig"} shows the renal ultrasound image. The entire kidneys were slightly atrophic. There was hepatorenal echo contrast in an opposite manner and increased echogenicity of the renal medulla and cortex. A hypertrophic column of Bertin was present with an increased echogenicity, and the contrast between the columns and the medullary pyramid was evident.

Figure [3](#F3){ref-type="fig"}, Figure [4](#F4){ref-type="fig"}, and Figure [5](#F5){ref-type="fig"} show the histological findings of renal tissue. There were no significant changes in the glomeruli, and infiltration of inflammatory cells in the tubulointerstitium was observed (Fig. [3](#F3){ref-type="fig"}). There were renal tubules containing a clear or crystal substance (Fig. [4](#F4){ref-type="fig"}), and the contents were positive for Kossa stain (Fig. [5](#F5){ref-type="fig"}). They were hyperechoic under a polarizing microscope.

Based on these findings, the patient was diagnosed with oxalate nephropathy. We took a careful dietary history, including the presence/absence of biased nutrition. However, she had no obvious biased nutrition. The patient was not taking other drugs or supplements. It was revealed that her daily water intake was 1 L or less. We considered that the reduced water intake might have been an aggravating factor and encouraged the patient to drink more water. Pyridoxine 10 mg and potassium citrate-citrate sodium 2 g were started. After that, her serum Cr decreased gradually to 2.9 mg/dL 1 month later, 2.8 mg/dL 2 months later, and to 2.1 mg/dL 1 year later and then remained at the same level.

Discussion {#sec1_3}
==========

The pathogenesis of hereditary oxalate nephropathy is under intense investigation, and 3 genetic types have been reported \[[@B3]\]. The disease is inherited in an autosomal recessive fashion and caused by abnormality of the enzyme involved in glyoxylate metabolism. The prognosis of this condition is poor because patients develop hepatic failure or renal failure due to deposition of oxalate in the organs when they reach adulthood. It is clear that our case does not fall into this category.

Regarding acquired oxalate nephropathy, it is well known that acute renal failure from acute oxalate nephropathy is caused by ingestion of large amounts of ethylene glycol (usually as a suicide attempt) \[[@B2]\]. A study reported that ingestion of large amounts of ascorbic acid can cause acute renal failure because ascorbic acid is metabolized to oxalate \[[@B6]\], while another recent study denied the hypothesis \[[@B7], [@B8]\].

Regarding the chronic condition, calcium oxalate is a well-known component of urinary stones, which are known to cause renal dysfunction in a huge number of cases \[[@B9]\]. However, chronic oxalate nephropathy due to deposition of oxalate in renal tissue is rare. It is, therefore, assumed that pathological deposition of oxalate is not observed in the general population. Previous studies reported that the condition is associated with ingestion of large amounts of foods and supplements containing oxalate, such as tea \[[@B10]\], spinach \[[@B11]\], and ascorbic acid \[[@B7]\]. There are also case reports of oxalate nephropathy following ingestion of large amounts of *Averrhoa bilimbi* juice \[[@B12]\] or rhubarb \[[@B13]\]. However, our patient did not have habitual intake of such foods.

Recently, an association between oxalate nephropathy and gastrointestinal surgery has been reported \[[@B14]\]. Case reports of calcium oxalate urinary stones associated with jejunoileal bypass or Roux-en-Y gastric bypass for obesity have been published. Although our patient had not undergone such a surgery, she had undergone small bowel resection for intestinal obstruction. As the patient had short bowel syndrome, it is speculated that her impaired fat absorption increased fat in the intestine, which decreased free Ca^2+^ due to binding of Ca^2+^ to the intestinal fat. This may have caused calcium oxalate to decrease and free oxalate to increase, which increased absorption of oxalate in blood, leading to deposition of oxalate in renal tissue \[[@B15]\].

In addition to the small bowel resection, our patient had undergone cholecystectomy after having small bowel resection. After cholecystectomy, her chronic diarrhea had been aggravated. It was assumed that resection of the gallbladder resulted in a further aggravation of enteric malabsorption of fat, thereby causing the deposition of oxalate. It is assumed that her calcium oxalate urinary stones 8 years before and oxalate nephropathy at present have the same underlying mechanism. The aggravation of renal dysfunction in recent years might be related to aggravation of chronic diarrhea with age and deterioration of the intestinal environment due to reduced water intake and other causes.

A further element of note in this case was our patient\'s characteristic echo findings. The increased echogenicity of the renal medulla and cortex and column of Bertin was probably due to deposition of calcium oxalate. Therefore, when an ultrasound examination shows these features, clinicians should consider the possible diagnosis of oxalate nephropathy.

In conclusion, we report a case of chronic oxalate nephropathy due to short bowel syndrome. It is possible that not only short bowel syndrome but also cholecystectomy may affect the onset of the disease.
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###### 

Test results on admission

  ---------------------------------------- --------- ---------
  **Blood chemistry**                                
  Total Protein (6.5\~8.0)                 6.5       g/dL
  Albumin (3.8\~5.3)                       3.9       g/dL
  AST (10\~34)                             17        1U/L
  ALT (l3\~30)                             14        1U/L
  LDH (124\~222)                           206       1U/L
  γ-GTP (5\~24)                            11        1U/L
  BUN (8\~20)                              48        mg/dL
  Cre (0.4\~1.0)                           3.36      mg/dL
  Uric acid (2.5\~6.0)                     5.6       mg/dL
  Sodium (135\~148)                        140       mEq/L
  Potassium (3.6\~5.0)                     3.8       mEq/L
  Calcium (8.4\~10.2)                      8.2       mg/dL
  **Complete blood count**                           
  White blood cells (3,000\~8,000)         4400      /µL
  Hb (11.5\~14.7)                          12.4      g/dL
  Blood platelets (1,620,000\~3,290,000)   140,000   /µL
  **Blood gas analysis**                             
  pH (7.35\~7.45)                          7.306     
  pCO~2~ (35\~45)                          29.9      mm Hg
  HCO~3~ (22\~26)                          14.6      mEq/L
  Base excess (−2\~+2)                     −10.6     mEq/L
  **Others**                                         
  PR3-ANCA                                 \<1.0     U/mL
  MPO-ANCA                                 \<1.0     U/mL
  intact-PTH (15\~65)                      162       pg/mL
  erythropoietin (4\~23)                   6.9       mIU/mL
  **Urinalysis**                                     
  Urine protein                            2.2       g/g×Cr
  Occult blood                                       (−)
  Glucose                                            (3+)
  β2MG/Cr (1\~300)                         215,260   µg/g×Cr
  NAG/Cr (1.6\~5.8)                        21.9      U/g×Cr
  Transferrin (0\~100)                     4,465     µg/gxCr
  ---------------------------------------- --------- ---------

Values in parentheses show the reference values. AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; γ-GTP, gamma-glutamyltransferase; BUN, blood urea nitrogen; Cr, creatinine; Hb, hemoglobin; intact-PTH; intact-parathormone; β2MG/Cr, beta 2-microglobulin/Cr ratio; NAG/Cr, N-acetyl-β-D-glucosaminidase/Cr ratio.
